Rhelion Life Sciences Corp. (TRUFF)
OTC
0.0210
+0.0010 (+5.00%)
Closed
Oct 7, 2026
Day's Range
0.02100.0210
52 wk Range
0.005000.0430
Financial Statements - TRUFF - Rhelion Life Sciences Corp.
Revenue
4.19M▼ 15.1%
Net Income
-6.84M▼ 58.9%Net Margin -163.2%
EBITDA
-3.50M▼ 23.6%
Free Cash Flow
-3.64M▼ 81.1%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 4.19M | 4.94M | 4.75M | 3.94M | 2.32M | 110.95K |
| Cost of Goods | 2.60M | 3.03M | 2.73M | 2.24M | 1.70M | 91.60K |
| Gross Profit | 1.59M | 1.91M | 2.02M | 1.70M | 617.67K | 19.34K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -4.12M | -4.21M | -6.18M | -4.95M | -9.50M | -4.64M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.24M | -408.67K | -1.85M | -1.16M | -5.44M | 2.99M |
| Pre Tax Income | -7.17M | -4.41M | -7.77M | -5.96M | -14.94M | -1.64M |
| Income Tax | -325.70K | -107.22K | -59.19K | -159.50K | -246.40K | 0 |
| Net Income | -6.84M | -4.30M | -7.71M | -5.80M | -14.69M | -1.64M |
| EPS Basic | -0.014647 | -0.01 | -0.02 | -0.01 | -0.04 | -0.01 |
| EPS Diluted | -0.014647 | -0.01 | -0.02 | -0.01 | -0.04 | -0.01 |
| Basic Shares Outstanding | 416.59M | 401.11M | 395.21M | 547.46M | 515.60M | 309.36M |
| Diluted Shares Outstanding | 416.59M | 401.11M | 395.21M | 547.46M | 515.60M | 309.36M |
| Ebit | -7.11M | -4.13M | -7.51M | -5.90M | -14.89M | -1.63M |
| Ebitda | -3.50M | -2.83M | -4.72M | -4.17M | -8.19M | -4.56M |
| Net Income Continuous Operations | -6.84M | -4.30M | -7.71M | -5.80M | -14.69M | -1.64M |
| Minority Interests | 742.96K | 265.58K | 86.51K | 402.45K | 328.04K | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
